Diabetes Mellitus Type 2 News

• More Than Half of US Women Enter Pregnancy at Higher CVD Risk Less than half of women in the United States enter pregnancy in favorable cardiovascular health, new research suggests.
  Medscape Medical News, February 24, 2022
• Gastric Bypass Best Option for Severe Obesity With Diabetes? Roux-en-Y gastric bypass led to 'improved health outcomes without costing a significant amount of money' in patients with severe obesity and type 2 diabetes of any severity, says a study author.
  Medscape Medical News, February 24, 2022
• Alert FDA Moves Generic Dapagliflozin a Step Closer to US Sales The FDA added two different dose formulations of generic dapagliflozin to its Orange Book of therapeutic equivalents, but a patent barrier remains in place.
  FDA Approvals, February 23, 2022
• Obesity, Diabetes in Women Linked to Their Birth Weight Findings from Chinese women showed a U-shaped relationship between birth weight and adult obesity, and increased birth weight was linked with reduced risk for type 2 diabetes in normal-weight women.
  First Look, February 23, 2022
• Consider Fatty Liver Disease for Hypoglycemia Risk in Diabetes 'Considering the high prevalence of [nonalcoholic fatty liver disease] in patients with type 2 diabetes, the contribution of NAFLD to hypoglycemia risk is not negligible,' say the study authors.
  Medscape Medical News, February 23, 2022
• Next-Generation Dexcom CGM, G7, Accurate and Easier to Use The Dexcom G7 continuous glucose monitor for patients with diabetes will include several features considered to be improvements over the G6 version.
  Medscape Medical News, February 22, 2022
• Full-press Therapy Rare in Diabetes With ASCVD Although many patients with diabetes also have cardiovascular disease, researchers have found a "shocking underuse" of medications to lower cholesterol, blood pressure and glucose in new observational data.
  Medscape Medical News, February 19, 2022
• Lactation Laws Seen Worsening Breastfeeding Disparities How do you get health professionals, lawmakers, lactation providers, and the community on the same page, especially when it comes to addressing disparities in breastfeeding? It depends on who you ask.
  Medscape Medical News, February 19, 2022
• SGLT2 Inhibitors May Cut Repeat Syncope in Type 2 Diabetes A prospective, multicenter study suggests that sodium-glucose cotransporter 2 (SGLT2) inhibitors improve cardiac autonomic dysfunction and reduce vaso-vagal syncope in patients with type 2 diabetes and prior syncope.
  First Look, February 16, 2022
• PCOS Common in Adolescent Girls With Type 2 Diabetes Polycystic ovary syndrome is common in girls with type 2 diabetes, according to the authors of a new study, who say screening for PCOS is critical in this group.
  Medscape Medical News, February 15, 2022
• US Underuse of GLP-1RA, SGLT-2i in Type 2 Diabetes Persists A large, US study found that just 1 in 8 patients with type 2 diabetes received first-line medications for comorbid atherosclerotic cardiovascular disease, heart failure, and diabetic nephropathy.
  First Look, February 15, 2022
• FDA Okays 6-Month Implanted Eversense CGM for Diabetes Delayed by the COVID-19 pandemic, the Senseonics Eversense E3 System is expected to be available in the US in the second quarter of 2022 for use in adults with diabetes.
  Medscape Medical News, February 11, 2022
• Bill Seeks to Limit Out-of-Pocket Spending on Insulin The Massachusetts bill would eliminate deductibles and coinsurance and permanently cap co-pays at $25 for a 30-day supply of insulin.
  Associated Press, February 11, 2022
• Update on Advice for Physical Activity in Type 2 Diabetes A new consensus statement from the American College of Sports Medicine recommends that all individuals with type 2 diabetes should engage in regular physical activity and reduce sedentary time.
  Medscape Medical News, February 11, 2022
• SMFM 2022 Benefits Limited for Early Gestational Diabetes Screening Screening pregnant women with obesity for gestational diabetes before 20 weeks of pregnancy did not lead to improved maternal or neonatal outcomes compared with routine screening between 24 and 28 weeks.
  Medscape Medical News, February 10, 2022
• Do Latest SURPASS Findings With Twincretin in Diabetes Impress? SURPASS-5 is latest published trial of a novel investigational once-weekly twincretin drug; editorialist says it leaves a number of unanswered questions about how best to use tirzepatide, if approved.
  Medscape Medical News, February 10, 2022
• Heavy Cannabis Use Tied to Less Diabetes in Women Women, but not men, who used marijuana at least four times in the previous month were less likely to have type 2 diabetes than nonusers, found a observational US study.
  Medscape Medical News, February 09, 2022
• New Conditions Rise Sharply After COVID-19 Hospitalization Type 2 diabetes onset, shortness of breath, and fatigue were more common in COVID-19 survivors, especially those with severe illness.
  Medscape Medical News, February 08, 2022
• Eating Dinner Late Ups Diabetes Risk; Melatonin Involved 'Try not to eat within 2 hours of bedtime,' is the message from a new study that found late eating acutely impairs glucose tolerance through a defect in insulin secretion.
  Medscape Medical News, February 08, 2022
• SGLT2 in Patients With Type 2 Diabetes Lowers Risk of Gout A retrospective, adjusted analysis of people in China with type 2 diabetes significantly linked SGLT2 inhibitor use with a lower risk of gout compared with those receiving a DPP4 inhibitor.
  First Look, February 08, 2022